What is the share price of Medicamen Organics Ltd (MEDIORG) today?
The share price of MEDIORG as on 15th July 2025 is ₹37.80. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Medicamen Organics Ltd (MEDIORG) share?
The past returns of Medicamen Organics Ltd (MEDIORG) share are- Past 1 week: -0.87%
- Past 1 month: -15.34%
- Past 3 months: 43.73%
- Past 6 months: -28.21%
- Past 1 year: -68.71%
- Past 3 years: N/A%
- Past 5 years: -73.88%
What are the peers or stocks similar to Medicamen Organics Ltd (MEDIORG)?
The peers or stocks similar to Medicamen Organics Ltd (MEDIORG) include:What is the market cap of Medicamen Organics Ltd (MEDIORG) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Medicamen Organics Ltd (MEDIORG) is ₹46.51 Cr as of 15th July 2025.What is the 52 week high and low of Medicamen Organics Ltd (MEDIORG) share?
The 52-week high of Medicamen Organics Ltd (MEDIORG) is ₹126 and the 52-week low is ₹19.60.What is the PE and PB ratio of Medicamen Organics Ltd (MEDIORG) stock?
The P/E (price-to-earnings) ratio of Medicamen Organics Ltd (MEDIORG) is 11.48. The P/B (price-to-book) ratio is 3.06.Which sector does Medicamen Organics Ltd (MEDIORG) belong to?
Medicamen Organics Ltd (MEDIORG) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Medicamen Organics Ltd (MEDIORG) shares?
You can directly buy Medicamen Organics Ltd (MEDIORG) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Medicamen Organics Ltd
MEDIORG Share Price
MEDIORG Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
HighStrong financials and growth story over the years
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MEDIORG Performance & Key Metrics
MEDIORG Performance & Key Metrics
No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
---|---|---|
— | 3.06 | — |
Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
---|---|---|
37.43 | 6.45 | 0.81% |
MEDIORG Analyst Ratings & Forecast
Price Upside
Earnings Growth
Rev. Growth
MEDIORG Company Profile
Medicamen Organics is an India-based pharmaceutical company engaged in developing, manufacturing, and distributing a range of pharmaceutical dosages for governments and private institutions as a contract manufacturer/third party manufacturer.
MEDIORG Forecast
MEDIORG Forecasts
MEDIORG
MEDIORG
Income
Balance Sheet
Cash Flow
MEDIORG Income Statement
MEDIORG Income Statement
Financial Year | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | 31.58 | 25.06 | 21.19 | 22.97 | 25.29 | 38.28 | — | |||||||
Raw Materials | 15.91 | 15.31 | 14.12 | 10.56 | 10.64 | 31.60 | — | |||||||
Power & Fuel Cost | 1.20 | 0.91 | 0.72 | 0.82 | 0.97 | |||||||||
Employee Cost | 2.58 | 2.33 | 2.49 | 2.87 | 3.02 | |||||||||
Selling & Administrative Expenses | 1.59 | 1.80 | 1.47 | 1.47 | 1.41 | |||||||||
Operating & Other expenses | 8.86 | 3.06 | 0.98 | 4.56 | 4.50 | |||||||||
EBITDA | 1.44 | 1.65 | 1.41 | 2.69 | 4.75 | 6.68 | — | |||||||
Depreciation/Amortization | 0.77 | 0.68 | 0.68 | 0.71 | 0.72 | 0.74 | — | |||||||
PBIT | 0.67 | 0.97 | 0.73 | 1.98 | 4.03 | 5.94 | — | |||||||
Interest & Other Items | 0.46 | 0.48 | 0.47 | 0.61 | 0.65 | 0.51 | — | |||||||
PBT | 0.21 | 0.49 | 0.26 | 1.37 | 3.38 | 5.43 | — | |||||||
Taxes & Other Items | 0.10 | 0.20 | 0.16 | 0.39 | 0.98 | 1.38 | — | |||||||
Net Income | 0.11 | 0.29 | 0.10 | 0.98 | 2.40 | 4.05 | — | |||||||
EPS | 0.18 | 0.48 | 0.17 | 1.63 | 3.29 | 3.67 | — | |||||||
DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |||||||
Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — |
MEDIORG Company Updates
MEDIORG Stock Peers
MEDIORG Past Performance & Peer Comparison
MEDIORG Past Performance & Peer Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
---|---|---|---|
Medicamen Organics Ltd | 11.48 | 3.06 | — |
Sun Pharmaceutical Industries Ltd | 36.94 | 5.57 | 0.95% |
Cipla Ltd | 22.73 | 3.83 | 1.08% |
Torrent Pharmaceuticals Ltd | 60.29 | 15.18 | 0.94% |
MEDIORG Stock Price Comparison
Compare MEDIORG with any stock or ETFMEDIORG Holdings
MEDIORG Shareholdings
MEDIORG Promoter Holdings Trend
MEDIORG Promoter Holdings Trend
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant
MEDIORG Institutional Holdings Trend
MEDIORG Institutional Holdings Trend
No institutional holdings trend are available
MEDIORG Shareholding Pattern
MEDIORG Shareholding Pattern
MEDIORG Shareholding History
MEDIORG Shareholding History
smallcases containing MEDIORG stock
smallcases containing MEDIORG stock
Looks like this stock is not in any smallcase yet.
MEDIORG Events
MEDIORG Events
MEDIORG Dividend Trend
MEDIORG has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
MEDIORG Dividend Trend
MEDIORG has not given any dividends in last 5 years
MEDIORG Dividends
MEDIORG Dividends
MEDIORG Stock News & Opinions
MEDIORG Stock News & Opinions
Medicamen Organics will hold a meeting of the Board of Directors of the Company on 29 May 2025.Powered by Capital Market - Live
Medicamen Organics will hold a meeting of the Board of Directors of the Company on 8 January 2025.Powered by Capital Market - Live
Medicamen Organics will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live
Medicamen Organics announced that the 29th Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live
Over the last 5 years, revenue has grown at a yearly rate of 3.92%, vs industry avg of 10.15%
Over the last 5 years, market share stayed at 0.01%
Over the last 5 years, net income has grown at a yearly rate of 105.69%, vs industry avg of 20.04%